subject: Amyotrophic Lateral Sclerosis (lou Gehrig's) - Drug Pipeline Analysis And Market Forecasts To 2016 [print this page] Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
Amyotrophic lateral sclerosis (Lou Gehrigs) - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global amyotrophic lateral sclerosis market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shaping and driving the global amyotrophic lateral sclerosis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global amyotrophic lateral sclerosis sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.
Scope
The scope of the report includes:
- Annualized global ALS market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan.
- Pipeline analysis data providing a split across different phases by mechanism of action being developed, and emerging trends. Key classes of mechanism of action include SOD1 protein folding stabilizers, dopamine agonists, immunomodulators and antioxidants.
- Analysis of the current and future market competition in the global ALS market. Key market players covered are Mitsubishi Tanabe Pharma Corporation, Avanir Pharmaceuticals, Avicena Group and Eisai Pharmaceuticals.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with ALS.
